Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02794 (
ferritin
)
17,525
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
NADH-lipoamide dehydrogenase mobilized iron from
ferritin
under aerobic conditions. Superoxide dismutase strongly inhibited this mobilization, indicating that the superoxide radical is generated by the enzymatic reaction and release iron from
ferritin
. Addition of lipoamide as an electron acceptor to NADH-lipoamide dehydrogenase increased the release of iron from
ferritin
and this release was partially inhibited by superoxide dismutase. Similarly, addition of menadione (2-methyl-1, 4-naphthoquinone) as an electron acceptor to xanthine-xanthine oxidase promoted the release of iron from
ferritin
and this release was strongly inhibited by superoxide dismutase. These results suggest that
dihydrolipoamide
and semiquinone of menadione can react with oxygen to form the superoxide radical that mediates release of iron from
ferritin
.
...
PMID:Superoxide-mediated release of iron from ferritin by some flavoenzymes. 215 90
The naturally occurring dithiols DL-dihydrolipoate and DL-
dihydrolipoamide
were tested for their ability in the removal of
ferritin
-bound iron. Both compounds remove the iron stored inside the protein by complexing it in the ferric form. The iron can be reduced to the ferrous form by excess dithiol, but this is not necessary for complete removal. Reaction is complete in few hours and, at molar ratios of chelator to metal higher than 10, more than 60% of the
ferritin
-bound iron was removed. The amount of iron stored in the
ferritin
molecule does not affect the rate and the yield of the removal reaction. The iron-removing ability of DL-dihydrolipoate was found to be identical to that of an equimolar solution of sodium dithionite, and to be pH-dependent. Results are discussed in terms of the molecular architecture of
ferritin
and of the chelators, and their possible physiological relevance is pointed out.
...
PMID:Removal of ferritin-bound iron by DL-dihydrolipoate and DL-dihydrolipoamide. 308 24
The nonenzymatic reactions of
dihydrolipoamide
with a number of low-potential quinones, possessing either a fully or a partially substituted quinone ring at pH 7.0 were accompanied by consumption of oxygen in a significant excess of the quinone concentration, thus establishing their redox cycling. Contrary to this, only partially substituted quinones caused the consumption of oxygen in the presence of reduced glutathione due to reoxidation of reduced quinone-glutathione conjugates. Among compounds tested, 9,10-phenanthrene quinone catalyzed the most rapid consumption of oxygen in the presence of
dihydrolipoamide
with subsequent formation of lipoamide and H2O2. The rate constant of anaerobic reduction of phenanthrene quinone by
dihydrolipoamide
was 8.6 +/- 1.6 x 10(3) M-1 s-1 (pH 7.0, 0.1 M phosphate, 20% ethanol, 25 degrees C). The consumption of oxygen and formation of lipoamide were inhibited by superoxide dismutase, indicating that the redox cycling involves the autooxidation of 9,10-dihydroxy phenanthrene, mediated by superoxide. The reaction was accompanied by the reduction of added cytochrome c, which was insignificantly inhibited by superoxide dismutase, and the reductive mobilization of iron from
ferritin
, activated by superoxide dismutase. These data raise the possibility that
dihydrolipoamide
, usually regarded as an antioxidant, under certain conditions may exert moderate prooxidant activity, initiating the formation of radicals and activated forms of oxygen.
...
PMID:Dihydrolipoamide-mediated redox cycling of quinones. 838 46